Goblet cell rebound and airway dysfunction with corticosteroid withdrawal in a mouse model of asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 178, Issue 11, 2008, Pages 1115-1122

  Southam, David S ^a   Ellis, Russ ^a   Wattie, Jennifer ^a   Glass, William ^b   Inman, Mark D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Centecor R and D   (United States)

Author keywords

Airway resistance; Asthma; Glucocorticoids; Goblet cells; Pathophysiology

Indexed keywords

BUDESONIDE; FLUTICASONE; HOUSE DUST ALLERGEN; INTERLEUKIN 13; MUCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; CONTROLLED STUDY; FEMALE; GOBLET CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GOBLET CELLS; HYPERPLASIA; INTERLEUKIN-13; MICE; MICE, INBRED BALB C; RESPIRATORY SYSTEM;

EID: 56749105447     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200801-084OC     Document Type: Article

References (31)

1. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002;53:477-498.
2. Dorscheid DR, Wojcik KR, Sun S, Marroquin B, White SR. Apoptosis of airway epithelial cells induced by corticosteroids. Am J Respir Crit Care Med 2001;164:1939-1947.
3. Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, Willems LN, Sterk PJ. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996;51:496-502.
4. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
5. Hansel TT. How do we measure the effectiveness of inhaled corticosteroids in clinical studies? Respir Med 2004;98:S9-S15.
6. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-336.
7. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
8. Fujimoto K, Yamaguchi S, Urushibata K, Hanaoka M, Koizumi T, Honda T, Kubo K. Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness. Intern Med 2006;45:843-849.
9. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-1234.
10. Rogers DF. Airway mucus hypersecretion in asthma: an undervalued pathology? Curr Opin Pharmacol 2004;4:241-250.
11. Fahy JV. Goblet cell and mucin gene abnormalities in asthma. Chest 2002;122:320S-326S.
12. Rogers DF. Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? Clin Exp Allergy 2002;32:1124-1127.
13. White SR, Dorscheid DR. Corticosteroid-induced apoptosis of airway epithelium: a potential mechanism for chronic airway epithelial damage in asthma. Chest 2002;122:278S-284S.
14. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF Jr, Strunk RC, Allen DB, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-1997.
15. Inman MD, Ellis R, Wattie J, Denburg JA, O'Byrne PM. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 1999;21:473-479.
16. Leigh R, Ellis R, Wattie J, Southam DS, De Hoogh M, Gauldie J, O'Byrne PM, Inman MD. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2002;27:526-535.
17. Southam DS, Ellis R, Wattie J, Inman MD. Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. J Allergy Clin Immunol 2007;119:848-854.
18. Leigh R, Southam DS, Ellis R, Wattie JN, Sehmi R, Wan Y, Inman MD. T-cell-mediated inflammation does not contribute to the maintenance of airway dysfunction in mice. J Appl Physiol 2004;97:2258-2265.
19. Yang G, Li L, Volk A, Emmell E, Petley T, Giles-Komar J, Rafferty P, Lakshminarayanan M, Griswold DE, Bugelski PJ, et al. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice. J Pharmacol Exp Ther 2005;313:8-15.
20. Ellis R, Leigh R, Southam D, O'Byrne PM, Inman MD. Morphometric analysis of mouse airways after chronic allergen challenge. Lab Invest 2003;83:1285-1291.
21. Southam DS, Widmer N, Ellis R, Hirota JA, Inman MD, Sehmi R. Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. J Allergy Clin Immunol 2005;115:95-102.
22. Rogers DF. The airway goblet cell. Int J Biochem Cell Biol 2003;35:1-6.
23. Rose MC, Nickola TJ, Voynow JA. Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am J Respir Cell Mol Biol 2001;25:533-537.
24. Fahy JV. Remodeling of the airway epithelium in asthma. Am J Respir Crit Care Med 2001;164:S46-S51.
25. Wiley RE, Cwiartka M, Alvarez D, Mackenzie DC, Johnson JR, Goncharova S, Lundblad L, Jordana M. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J Immunol 2004;172:4995-5005.
26. Leigh R, Ellis R, Wattie J, Donaldson DD, Inman MD. Is interleukin-13 critical in maintaining airway hyperresponsiveness in allergen-challenged mice? Am J Respir Crit Care Med 2004;170:851-856.
27. Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, O'Byrne PM, Inman MD. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004;169:860-867.
28. Tliba O, Deshpande D, Chen H, Van BC, Kannan M, Panettieri RA Jr, Amrani Y. IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol 2003;140:1159-1162.
29. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005.
30. Becker A, Bérubé D, Chad Z, Dolovich M, Ducharme F, D'Urzo T, Ernst P, Ferguson A, Gillespie C, Kapur S, et al; Canadian Network for Asthma Care; Canadian Thoracic Society. Canadian pediatric asthma consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ 2005;173(6, Suppl)S12-S14.
31. Gold DR, Fuhlbrigge AL. Inhaled corticosteroids for young children with wheezing. N Engl J Med 2006;354:2058-2060.